Language Selector

    Good News for Swiss Scientists Applying for Innovative Medicines Initiative (IMI) Funding

    Published on 03 February 2017
    Author: Sasha Hugentobler, National Contact Point Health, Demographic Change & Wellbeing

    Swiss researchers and organisations can now fully participate in the whole Horizon 2020 programme, including IMI, on equal terms with entities from EU Member States and other associated countries.

    Switzerland became fully associated to Horizon 2020 on 1 January 2017 following the country’s ratification, on 16 December 2016, of the Protocol extending the EU-Switzerland Free Movement of Persons agreement to Croatia. From December 2014 to December 2016, Swiss scientists could only receive funding under parts of Horizon 2020 (not including IMI).

    ‘Switzerland has now fulfilled the EU's condition on free movement of people and can be fully associated to Horizon 2020,’ said Carlos Moedas, EU Commissioner for Research, Science and Innovation. ‘This is good news for Switzerland, and good news for the EU. It will further strengthen our scientific communities and our very substantial cooperation in research and innovation.’ The Swiss have already nominated an IMI States Representatives Group (SRG) member – Isabella Beretta.

    Among other things, SRG members can provide advice to local researchers on applying for IMI funding and help them to find partners.

    Further Information